2009-06-29 14:49 Helsingborg June 29th 2009- DuoCort publishes data from its Phase I study for the rare and life threatening disease adrenal insufficiency. The release profile of DuoCort’s new form of treatment with once-a-day hydrocortisone dosing resembles the physiological secretion pattern. The data is published today in the European Journal of Endocrinology, a leading scientific journal for endocrinology.
Nyhet
Maria Forss selected in Swedish Initiative for Women Board Members
2009-11-06 00:12Wednesday, 01 July 2009
PULS's Head of Business Development, Maria Forss, is one of the 200 women selected by Maud Olofsson, the Minister for Enterprise and Energy and Deputy Prime Minister, in collaboration with ALMI Företagspartner, to participate in the Styrelsekraft program. This is a national mentoring program targeting qualified and experienced women who have the ambition to be board members of both private and public companies.
The Styrelsekraft program will run for one year. Each participant is matched with a mentor and will participate in networking meetings. She will also receive a scholarship for Board-level education.
Maria Forss says "I am really excited to be given this opportunity, especially since so many qualified women applied to the program. This gives me the chance to broaden both my theoretical knowledge and practical experience, as well as giving me an external mentor and expanding my network".
Maria Forss has a Master of Science of in Business Administration and has been part of the senior management team at PULS since August 2008. Forss is also the project manager for DuoCort Pharma AB and a member of the board of Laccure AB.
Kategorisering
- Tags:
- maria forss,
- styrelsekraft,
- p.u.l.s.,
- duocort pharma,
- laccure,
- almi
Lägg till kommentarKommentaren sparades
Innan den publiceras måste den godkännas av P.U.L.S. AB.